CLINICAL_TRIALS
trial_result
· 2014-05-26
Clinical Trial Update: Once-Daily Asenapine for Schizophrenia [Phase 4]
Summary
A Phase 4 clinical trial update on once-daily asenapine for schizophrenia, with the study completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-05-26